Akebia Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 06 2020 - 8:00AM
Business Wire
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical
company focused on the development and commercialization of
therapeutics for people living with kidney disease, today announced
that its President and Chief Executive Officer, John P. Butler,
will present at the 38th Annual J.P. Morgan Healthcare Conference
on Wednesday, January 15, 2020 at 9:30 a.m. PT in San
Francisco.
A live webcast and replay of Akebia’s presentation and
associated Q&A will be available on the Company’s website at
www.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated
biopharmaceutical company focused on the development and
commercialization of therapeutics for people living with kidney
disease. The Company was founded in 2007 and is headquartered in
Cambridge, Massachusetts. For more information, please visit our
website at www.akebia.com, which does not form a part of this
release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200106005186/en/
Kristen K. Sheppard, Esq. ir@akebia.com
Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Apr 2023 to Apr 2024